# Filgrastim

## Gcsf 150mcg/0.6mL \(Filgrastim\)

| 藥物代碼 | IGCS |
| :--- | :--- |
| 適應症 | Mobilization of hematopoietic progenitor cells to peripheral blood, Acceleration of an increase in the number of neutrophils following hematopoietic progenitor cells transplantation, Neutropenia caused by cancer chemotherapy, Neutropenia accompanying MDS, Congenital idiopathic neutropenia. |
| 副作用 | Mainly bone pain, fever, redness, nausea & vomiting, headache.Gastrointestinal: Nausea and vomiting \(57% \)Musculoskeletal: Bone pain \(22% to 33% \) |
| 禁忌 | NA |
| 藥物保存方式 | 避光冷藏 \(&lt;10℃\) |
| 用法用量 | Mobilization of hematopoietic progenitor cells to peripheral blood. Adult & children Administer 400 mcg/m2 once daily SC. Acceleration of an increase in the number of neutrophils following hematopoietic progenitor cells transplantation Adult & children Administer 300 mcg/m2 once daily IV. Neutropenia caused by cancer chemotherapy Adult & children Administer 200 mcg/m2 once daily IV. Neutropenia accompanying MDS Neutrophil count ≦ 1000/mm3, 100 mcg/m2 once daily IV. Congenital idiopathic neutropenia Adult & children: Neutrophil count ≦ 1000/mm3, 50 mcg/m2 SC once daily. When neutrophil count ≧ 5000/mm3, close observation is needed & consideration should be made to either decrease dosage or discontinue therapy. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer′s labeling |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD, SC |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選  【N/S】 可選 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | IV輸注時可使用 D5W稀釋，濃度勿低於 5 mcg/mL。 |
| 注意事項 | 1. IV輸注時可使用 D5W稀釋，濃度勿低於 5 mcg/mL。 |

